Abstract

Increased knowledge about HIV-1 transmission dynamics in different transmission groups and geographical regions is fundamental for assessing and designing prevention efforts against HIV-1 spread. Since the first reported cases of HIV infection during the early 1980s, the HIV-1 epidemic in the Nordic countries has been dominated by HIV-1 subtype B and MSM transmission. HIV-1 pol sequences and clinical data of 51 per cent of all newly diagnosed HIV-1 infections in Sweden, Denmark, and Finland in the period 2000–2012 (N = 3,802) were analysed together with a large reference sequence dataset (N = 4,537) by trend analysis and phylogenetics. Analysis of the eight dominating subtypes and CRFs in the Nordic countries (A, B, C, D, G, CRF01_AE, CRF02_AG, and CRF06_cpx) showed that the subtype B proportion decreased while the CRF proportion increased over the study period. A majority (57 per cent) of the Nordic sequences formed transmission clusters, with evidence of mixing both geographically and between transmission groups. Detailed analyses showed multiple occasions of transmissions from MSM to heterosexuals and that active transmission clusters more often involved single than multiple Nordic countries. The strongest geographical link was between Denmark and Sweden. Finally, Denmark had a larger proportion of heterosexual domestic spread of HIV-1 subtype B (75 per cent) compared with Sweden (49 per cent) and Finland (57 per cent). We describe different HIV-1 transmission patterns between countries and transmission groups in a large geographical region. Our results may have implications for public health interventions in targeting HIV-1 transmission networks and identifying where to introduce such interventions.

Details

Title
HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries
Author
Esbjörnsson, Joakim 1 ; Mild, Mattias 2 ; Audelin, Anne 3 ; Fonager, Jannik 3 ; Skar, Helena 4 ; Louise Bruun Jørgensen 3 ; Liitsola, Kirsi 5 ; Björkman, Per 6 ; Bratt, Göran 7 ; Gisslén, Magnus 8 ; Sönnerborg, Anders 9 ; Nielsen, Claus 3 ; Medstrand, Patrik 10 ; Albert, Jan 11 

 Department of Microbiology Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden; Nuffield Department of Medicine, University of Oxford, Oxford, UK; REGA Institute, Katholieke Universiteit, Leuven, Belgium 
 Department of Microbiology, Public Health Agency of Sweden, Stockholm, Sweden 
 Department of Microbiological Diagnostics and Virology, Statens Serum Institut, Copenhagen, Denmark 
 Department of Science and Technology, Linköping University, Campus Norrköping, Norrköping, Sweden 
 Department of Infectious Diseases, National Institute for Health and Welfare, Helsinki, Finland 
 Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden 
 Department of Clinical Science and Education, Venhälsan, Stockholm South General Hospital, Stockholm, Sweden 
 Department of Infectious Diseases, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden 
 Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden; Division of Clinical Microbiology, Karolinska Institute, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden 
10  Department of Translational Medicine, Lund University, Malmö, Sweden 
11  Department of Microbiology Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden 
Publication year
2016
Publication date
Jan 2016
Publisher
Oxford University Press
e-ISSN
20571577
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3171768833
Copyright
© The Author 2016. Published by Oxford University Press. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.